TNL Mediagene Statistics
Total Valuation
TNL Mediagene has a market cap or net worth of $6.24 million. The enterprise value is $24.58 million.
Important Dates
The next estimated earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TNL Mediagene has 2.56 million shares outstanding. The number of shares has increased by 8.33% in one year.
| Current Share Class | 2.56M |
| Shares Outstanding | 2.56M |
| Shares Change (YoY) | +8.33% |
| Shares Change (QoQ) | +11.24% |
| Owned by Insiders (%) | 18.61% |
| Owned by Institutions (%) | 9.75% |
| Float | 2.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.13 |
| Forward PS | 0.06 |
| PB Ratio | 0.18 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.38, with a Debt / Equity ratio of 0.58.
| Current Ratio | 0.38 |
| Quick Ratio | 0.32 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -79.87 |
Financial Efficiency
Return on equity (ROE) is -164.59% and return on invested capital (ROIC) is -45.01%.
| Return on Equity (ROE) | -164.59% |
| Return on Assets (ROA) | -31.70% |
| Return on Invested Capital (ROIC) | -45.01% |
| Return on Capital Employed (ROCE) | -85.54% |
| Weighted Average Cost of Capital (WACC) | 4.47% |
| Revenue Per Employee | $93,901 |
| Profits Per Employee | -$157,660 |
| Employee Count | 529 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 306.07 |
Taxes
| Income Tax | -411,075 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.64% in the last 52 weeks. The beta is 1.24, so TNL Mediagene's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -91.64% |
| 50-Day Moving Average | 2.97 |
| 200-Day Moving Average | 6.60 |
| Relative Strength Index (RSI) | 37.70 |
| Average Volume (20 Days) | 13,205 |
Short Selling Information
The latest short interest is 119,590, so 4.68% of the outstanding shares have been sold short.
| Short Interest | 119,590 |
| Short Previous Month | 142,701 |
| Short % of Shares Out | 4.68% |
| Short % of Float | 5.75% |
| Short Ratio (days to cover) | 1.49 |
Income Statement
In the last 12 months, TNL Mediagene had revenue of $49.67 million and -$83.40 million in losses. Loss per share was -$63.49.
| Revenue | 49.67M |
| Gross Profit | 16.54M |
| Operating Income | -49.98M |
| Pretax Income | -83.78M |
| Net Income | -83.40M |
| EBITDA | -47.96M |
| EBIT | -49.98M |
| Loss Per Share | -$63.49 |
Full Income Statement Balance Sheet
The company has $1.90 million in cash and $20.24 million in debt, with a net cash position of -$18.34 million or -$7.17 per share.
| Cash & Cash Equivalents | 1.90M |
| Total Debt | 20.24M |
| Net Cash | -18.34M |
| Net Cash Per Share | -$7.17 |
| Equity (Book Value) | 34.86M |
| Book Value Per Share | 13.64 |
| Working Capital | -17.17M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$11.13 million and capital expenditures -$76,643, giving a free cash flow of -$11.21 million.
| Operating Cash Flow | -11.13M |
| Capital Expenditures | -76,643 |
| Free Cash Flow | -11.21M |
| FCF Per Share | -$4.39 |
Full Cash Flow Statement Margins
Gross margin is 33.30%, with operating and profit margins of -100.62% and -167.90%.
| Gross Margin | 33.30% |
| Operating Margin | -100.62% |
| Pretax Margin | -168.65% |
| Profit Margin | -167.90% |
| EBITDA Margin | -96.55% |
| EBIT Margin | -100.62% |
| FCF Margin | n/a |
Dividends & Yields
TNL Mediagene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.33% |
| Shareholder Yield | -8.33% |
| Earnings Yield | -1,337.08% |
| FCF Yield | -179.72% |
Analyst Forecast
The average price target for TNL Mediagene is $14.00, which is 473.77% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 473.77% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 23, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Dec 23, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
TNL Mediagene has an Altman Z-Score of -3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3 |
| Piotroski F-Score | 1 |